Long-term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.14926 ◽

2018 ◽

Vol 32 (8) ◽

pp. 1297-1304 ◽

Author(s):

R. Gniadecki ◽

C.L. Leonardi ◽

K.B. Gordon ◽

Y. Gu ◽

Z. Geng ◽

...

Keyword(s):

Plaque Psoriasis ◽

Severe Plaque Psoriasis

Download Full-text

Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up

British Journal of Dermatology ◽

10.1111/bjd.20595 ◽

2021 ◽

Author(s):

K.A. Papp ◽

M.G. Lebwohl ◽

L. Puig ◽

M. Ohtsuki ◽

S. Beissert ◽

...

Keyword(s):

Plaque Psoriasis ◽

Interim Analysis ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Term Efficacy ◽

Open Label Extension ◽

Extension Trial

Download Full-text

A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.012 ◽

2004 ◽

Vol 50 (3) ◽

pp. P2 ◽

Author(s):

Alan Menter ◽

Deborah Lew-Kaya ◽

Frederick Beddingfield ◽

Patricia S. Walker

Keyword(s):

Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis

Download Full-text

Long-term efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis sustained for three years: Results of a randomized controlled phase 3 study (UNCOVER-3)

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.732 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB180

Keyword(s):

Plaque Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Severe Plaque Psoriasis ◽

Randomized Controlled ◽

Download Full-text

Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2008.03039.x ◽

2009 ◽

Vol 23 (3) ◽

pp. 277-282 ◽

Author(s):

M Dalaker ◽

JH Bonesrønning

Keyword(s):

Plaque Psoriasis ◽

Retrospective Cohort ◽

Maintenance Treatment ◽

Severe Plaque Psoriasis ◽

Term Maintenance

Download Full-text

076. CONSISTENT SAFETY AND TOLERABILITY OF SECUKINUMAB OVER LONG-TERM EXPOSURE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND MODERATE TO SEVERE PLAQUE PSORIASIS: UPDATED POOLED SAFETY ANALYSES

Rheumatology ◽

10.1093/rheumatology/kex062.076 ◽

2017 ◽

Vol 56 (suppl_2) ◽

Author(s):

Philip J. Mease ◽

Iain B. McInnes ◽

Kristian Reich

Keyword(s):

Psoriatic Arthritis ◽

Plaque Psoriasis ◽

Severe Plaque Psoriasis

Download Full-text

Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)

British Journal of Dermatology ◽

10.1111/bjd.12404 ◽

2013 ◽

Vol 168 (6) ◽

pp. 1325-1334 ◽

Author(s):

K. Reich ◽

G. Wozel ◽

H. Zheng ◽

H.J.F. van Hoogstraten ◽

L. Flint ◽

...

Keyword(s):

Plaque Psoriasis ◽

Intermittent Therapy ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Extension Trial

Download Full-text

Long-term clinical safety and efficacy of brodalumab in the treatment of Japanese patients with moderate-to-severe plaque psoriasis

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.13785 ◽

2016 ◽

Vol 30 (11) ◽

pp. 1957-1960 ◽

Author(s):

Y. Umezawa ◽

H. Nakagawa ◽

H. Niiro ◽

K. Ootaki ◽

Keyword(s):

Plaque Psoriasis ◽

Japanese Patients ◽

Clinical Safety ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis

Download Full-text

Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature

Clinical Cosmetic and Investigational Dermatology ◽

10.2147/ccid.s4560 ◽

2010 ◽

pp. 49 ◽

Author(s):

Angela Moore

Keyword(s):

Plaque Psoriasis ◽

Review Of The Literature ◽

Severe Plaque Psoriasis

Download Full-text

Long-Term Improvements in Health-Related Quality of Life of Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.20 ◽

2021 ◽

Vol 5 (1) ◽

pp. s20

Author(s):

D Thaçi ◽

A Blauvelt ◽

K Reich ◽

RB Warren ◽

V Piguet ◽

...

Keyword(s):

Quality Of Life ◽

Plaque Psoriasis ◽

Certolizumab Pegol ◽

Health Related Quality ◽

Phase 3 ◽

Severe Plaque Psoriasis ◽

Related Quality ◽

Abstract not available.

Download Full-text

16310 Dimethyl fumarate as long-term treatment for moderate to severe plaque psoriasis in clinical practice: Interim data from the SKILL study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2020.06.789 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB175

Author(s):

Ismail Kasujee ◽

Matthias Augustin ◽

Astrid Kirsch ◽

Sebastian Diemert

Keyword(s):

Clinical Practice ◽

Plaque Psoriasis ◽

Dimethyl Fumarate ◽

Term Treatment ◽

Severe Plaque Psoriasis ◽

Long Term Treatment

Download Full-text